% | $
Quotes you view appear here for quick access.

Tejon Ranch Co. Message Board

clone14me 3 posts  |  Last Activity: Jun 5, 2016 4:17 PM Member since: Feb 27, 2002
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Motley Fool say's about MK

    by clone14me Jun 4, 2016 12:37 PM
    clone14me clone14me Jun 5, 2016 4:17 PM Flag

    Perhaps you should do a bit of due dillengence on the subject. MF has a large client base that includes private and commerical investors. Motley Fool produces a yearly list of promising drug candiates within the immuno arena and MK did not make the list for 2016 meaning share value is affected. However it is not just MF not one biotech investment advisor has listed MK as a game changer. MK is not even known within the medical trial community..Think I am wrong? Ask you doctor or dentist? Ask you broker for it's opinion.....We are deep in P-3 and still in a struggle to exist with not one take over candiate making thier interest known, not one leak from those in the trial and not one
    family office or brokerage firm interested in a take over or merger as Geert predicted when P-3 was approved.

  • nothing...Not one word. MK is not even listed and as top 10 immuno for 2016 by MF....

  • Reply to


    by jingledsassy May 27, 2016 8:58 AM
    clone14me clone14me May 27, 2016 2:55 PM Flag

    Investor and Media Relations
    Anna Krassowska, Ph.D.
    Tel: 650-473-7700
    E-mail: or

23.64+0.32(+1.37%)Jun 30 4:02 PMEDT